Phenolphthalein

CAS No. 77-09-8

Phenolphthalein ( Phenolphthalein; Euchessina; Phthalimetten; Chocolax; Espotabs )

Catalog No. M15915 CAS No. 77-09-8

An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 38 In Stock
1G 45 In Stock

Biological Information

  • Product Name
    Phenolphthalein
  • Note
    Research use only, not for human use.
  • Brief Description
    An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.
  • Description
    An acid-base indicator which is colorless in acid solution, but turns pink to red as the solution becomes alkaline. It is used medicinally as a cathartic.
  • Synonyms
    Phenolphthalein; Euchessina; Phthalimetten; Chocolax; Espotabs
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    77-09-8
  • Formula Weight
    318.33
  • Molecular Formula
    C20H14O4
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 400 mg/L
  • SMILES
    O=C1OC(C2=CC=C(O)C=C2)(C3=CC=C(O)C=C3)C4=CC=CC=C14
  • Chemical Name
    3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Uesawa Y, et al. Arch Toxicol. 2007 Mar;81(3):163-8.
molnova catalog
related products
  • AZ876

    AZ876 is a potent highly selective LXR agonist with Ki/EC50 of 7/6 nM and 11/73 nM for hLXRα and hLXRβ respectively.

  • LDN-192960

    LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM).

  • Bractoppin

    Bractoppin is a drug-like inhibitor of phosphopeptide recognition by the human BRCA1 tandem (t)BRCT domain (IC50 = 0.074 μM), which selectively inhibits substrate binding with nanomolar potency in vitro.